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Streptococcus pneumoniae isolates (6.5 %). Multi-drug resistant pattern F
consisted of EM, TC, and PCG. Pattern F was involved 4 Streptococcus pneu-
moniae isolates (2.6 %).
Conclusions: These results indicate the most multi-drug resistant Strepto-
coccus pneumoniae have macrolide resistant ability. The emergence of
multi-drug resistant Streptococcus pneumoniae suggest the need for
continuing surveillance of antimicrobial resistance.PS 1-021
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Purpose: High antibiotic consumption is related to increased health care
expenditure. We sought to decrease antibiotic consumption by optimizing
antibiotics prescribing in order to reduce hospital costs. The purpose of
this study was to evaluate the impact of the multidisciplinary team (infec-
tious diseases physicians and pharmacists) on antibiotics consumption and
expenditure.
Methods: Since March 2014, pharmacists reviewed orders for all inpatients
receiving broad-spectrum antibiotics with daily feedback to prescribers. In
addition, prescribers had to consult ID specialists while ordering restricted
antibiotics. Monthly broad-spectrum antibiotics consumption and expendi-
ture before (from March to September 2013) and during the intervention
(from March to September 2014) were compared. Broad-spectrum antibi-
otics consumption was calculated using Defined Daily Doses (DDD) per 1000
patient days.
Results: During the intervention period, pharmacists made 230 recommen-
dations. The average acceptance rate by prescribers was 65%. Comparing
antibiotic consumption of the same month in 2013 and 2014, a reduction
has been seen since June 2014 (from 6% in June up to 22% in September).
Antibiotic expenditure was reduced by an average of $487,763 TWD every
month since June 2014 comparing to drug costs of the same month in 2013.
Conclusions: A multidisciplinary antibiotic stewardship team can not only
help optimize patient antibiotics but also significantly improve antibiotics
utilization and expenditure.PS 1-022
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GYNAECOLOGY TERTIARY CARE HOSPITAL IN SINGAPORE: A SEVEN-YEAR
TREND ANALYSIS
Ong Yue Ling Rina a, Seah Xue Fen Valerie a, Chong Chia Yin b,c,d, Tan
Woon Hui Natalie b,c,d, Thoon Koh Cheng b,c,d. aDepartment of Pharmacy, KK
Women’s and Children’s Hospital, Singapore; bDepartment of Paediatric
Medicine e Infectious Disease Service, KK Women’s and Children’s Hospital,
Singapore; cDuke-National University of Singapore, Graduate Medical
School, Singapore; dYong Loo Lin School of Medicine, National University of
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Purpose: Surveillance of antibiotic consumption trends is a strategy to un-
derstand epidemiological changes in antibiotic prescribing. This study pre-
sents the seven-year trend of antibiotic consumption in an 830-bed
tertiary care hospital dedicated to Paediatrics and Obstetrics/Gynaecology
(OBGYN) services in Singapore from 2006 to 2012.
Methods: Antibiotic consumptiondatawas retrieved retrospectively fromphar-
macy purchasing records. Total antibiotic weight per 100 patient-days was
selected as the surrogate measure to trend consumption. Consumption trends
were analysed by linear regression analysis with logarithmic transformations.
Results: Overall antibiotic consumption in Paediatrics remained stable (r2Z
0.016, pZ 0.669) while there was an increase in OBGYN consumption (r2Z
0.929, p < 0.01). Significant increases were observed for both fluoroquino-
lones (Paediatrics: r2 Z 0.752, p < 0.01 vs. OBGYN: r2 Z 0.635, p < 0.01)
and extended-spectrum beta-lactams (Paediatrics: r2 Z 0.406, p < 0.05
vs. OBGYN: r2 Z 0.897, p < 0.01). In Paediatrics, piperacillin-tazobactam
demonstrated a marked three-fold increase (r2 Z 0.858, p < 0.01). Similartrends were observed in OBGYN with two-fold increases in piperacillin-tazo-
bactam (r2 Z 0.639, p < 0.01) and amoxicillin-clavulanate (r2 Z 0.897, p <
0.01) use. In Pediatrics, there was a decline in utilization of macrolides (r2Z
0.657, p < 0.01) and aminoglycosides (r2 Z 0.373, p < 0.05) whereas in
OBGYN, both macrolides (r2 Z 0.328, p < 0.05) and aminoglycosides con-
sumption increased (r2 Z 0.837, p < 0.01). Utilization of the other antibi-
otics remained stable.
Figure: Trends of extended-spectrum beta-lactams, fluoroquinolones, ami-
noglycosides and macrolides consumption in both paediatrics and OBGYN
services from FY 2006 to FY 2012.
Conclusions: Increased utilization of broad-spectrum antibiotics like fluoro-
quinolones and extended-spectrum beta-lactams may be results of existing
interventions or greater antimicrobial resistance with suboptimal responses
to first-line antimicrobial therapy. Longitudinal surveillance of antibiotic
consumption is essential in formulating interventions to advocate for more
judicious antibiotic prescribing.PS 1-023
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Purpose: The ESBL-producing Enterobacteriaceae rate did not decrease
despite reducing use of cephalosporins with oxyimino side chain in our hos-
pital, a teaching hospital in Taiwan. Our study aimed to survey the correla-
tions between the groups of cephalosporins with ESBL-producing
Enterobacteriaceae.
Methods: We conducted a retrospective cohort study during 2003 to 2013.
The strategy to reduce the use of cephalosporins with oxyimino side chain
was implemented since the second half of 2004. Two cephamycin group an-
tibiotics, cefmetazole and flomoxef, were available during the study period.
We analyzed the relationship between the consumption of cephalosproins
and hospital-acquired ESBL-producing Escherichia coli and Klebsiella pneu-
moniae rates by linear regression.
Results: The use of cefmetazole and flomoxef continuously increased from
11.10 and 5.21 DDDs/1000PDs respectively in the first half of 2003 to 24.28
and 28.93 DDDs/1000PDs in the second half of 2013. The rates of ESBL-produc-
ing E. coli showed an increase trend (from 9.6% in the first half of 2003 to 38.6%
in the second half of 2013), while the rate of ESBL-producing K. pneumoniae
varied during the study period. Cefmetazole use was positively correlated
with rates of ESBL-producing E. coli (p Z 0.002) and K. pneumoniae (p Z
0.013). Flomoxef and total cephamycin use were positively correlated with
rate of ESBL-producing E. coli (p Z 0.001 and p < 0.001, respectively), but
not with rate of ESBL-producing K. pneumoniae. Other third generation ceph-
alosporins, including ceftriaxone, cefotaxime and ceftazidime, did not have
correlation with ESBL-producing E. coli or K. pneumoniae.
Conclusions: The usage of cephamycin group was associated with ESBL-pro-
ducing E. coli and K. pneumoniae. Restriction the usage of cephalosporins
with oxyimino side chain only could not control the ESBL-producing Entero-
bacteriaceae rate effectively.
